A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE.
Tan L, Brown C, Mersiades A, Lee CK, John T, Kao S, Newnham G, O'Byrne K, Parakh S, Bray V, Jasas K, Yip S, Wong SQ, Ftouni S, Guinto J, Chandrashekar S, Clarke S, Pavlakis N, Stockler MR, Dawson SJ, Solomon BJ.
Tan L, et al.
Nat Commun. 2024 Feb 28;15(1):1823. doi: 10.1038/s41467-024-46008-1.
Nat Commun. 2024.
PMID: 38418463
Free PMC article.
Clinical Trial.